• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.

作者信息

Porter D L, Orloff G J, Antin J H

机构信息

Harvard Medical School, Boston, MA.

出版信息

Transplant Sci. 1994 Sep;4(1):12-4; discussion 14-6.

PMID:7804691
Abstract
摘要

相似文献

1
Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.
Transplant Sci. 1994 Sep;4(1):12-4; discussion 14-6.
2
Lymphocytosis of donor origin in cerebrospinal fluid, and marrow aplasia after donor leukocyte infusion for EBV-lymphoproliferative disease.
Bone Marrow Transplant. 1996 Jul;18(1):221-4.
3
Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
Important Adv Oncol. 1996:149-66.
4
Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Bone Marrow Transplant. 1996 Jul;18(1):257-9.
5
[Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
Rinsho Ketsueki. 2001 Nov;42(11):1105-10.
6
Alpha-interferon therapy for lymphoproliferative disorders developing in two children following bone marrow transplants.
J Biol Response Mod. 1989 Dec;8(6):603-13.
7
Isolated central nervous system Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.孤立性中枢神经系统爱泼斯坦-巴尔病毒相关移植后淋巴增殖性疾病
Pediatr Blood Cancer. 2011 May;56(5):871-2. doi: 10.1002/pbc.22910. Epub 2010 Nov 28.
8
Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.异基因HLA不匹配骨髓移植中T细胞和B细胞联合清除对骨髓移植受者外周血中EB病毒载量的大小和动力学的影响。
Clin Transplant. 2004 Oct;18(5):518-24. doi: 10.1111/j.1399-0012.2004.00198.x.
9
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.采用供体外周血淋巴细胞对骨髓移植后复发白血病进行异基因细胞治疗。
Exp Hematol. 1995 Dec;23(14):1553-62.
10
Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.使用供体淋巴细胞进行异基因细胞介导的免疫疗法，以预防接受异基因骨髓移植治疗血液系统恶性肿瘤的患者复发。
Clin Transpl. 1996:281-90.

引用本文的文献

1
Posttransplant chimeric antigen receptor therapy.移植后嵌合抗原受体治疗。
Blood. 2018 Mar 8;131(10):1045-1052. doi: 10.1182/blood-2017-08-752121. Epub 2018 Jan 22.
2
Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy.从急性淋巴细胞白血病患儿中生成肿瘤抗原特异性 T 细胞系 - 免疫治疗的意义。
Clin Cancer Res. 2013 Sep 15;19(18):5079-91. doi: 10.1158/1078-0432.CCR-13-0955. Epub 2013 Jul 9.
3
Cellular therapy following allogeneic stem-cell transplantation.
异基因造血干细胞移植后细胞治疗。
Ther Adv Hematol. 2011 Dec;2(6):409-28. doi: 10.1177/2040620711412416.
4
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.NCI 首次国际造血细胞移植后复发的生物学、预防和治疗专题研讨会：血液恶性肿瘤异基因细胞移植后预防复发专题委员会报告。
Biol Blood Marrow Transplant. 2010 Aug;16(8):1037-69. doi: 10.1016/j.bbmt.2010.05.005. Epub 2010 May 24.
5
Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.针对异基因骨髓移植后并发的爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的过继性免疫治疗。
Springer Semin Immunopathol. 1998;20(3-4):455-91. doi: 10.1007/BF00838055.
6
CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.CD40激活的人B细胞：一种高效抗原呈递细胞的替代来源，用于生成自体抗原特异性T细胞以进行过继性免疫治疗。
J Clin Invest. 1997 Dec 1;100(11):2757-65. doi: 10.1172/JCI119822.